mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.2 |
0.0001 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |